Breaking News

Evonik Breaks Ground for New Complex in Marl

Investing over €400 million to expand capacity for polyamide 12

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evonik began construction on its largest investment to date in Germany. The company is investing over €400 million to expand capacity for polyamide 12 (PA 12) by more than 50 percent at its largest site. The project will complement existing PA 12 production with additional plants for the polymer and its precursors. Startup is scheduled for 2021. Christian Kullmann, the chairman of the executive board of Evonik Industries AG said, “This is the biggest single investment our company has made in Ge...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters